Acumen Pharmaceuticals (ABOS) vs Armata Pharmaceuticals (ARMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Armata Pharmaceuticals (ARMP) has outperformed Acumen Pharmaceuticals (ABOS) over the past year, gaining 21.3% versus a gain of 11.7%. Over five years, ARMP leads with a +10.4% price change compared with -84.5% for ABOS. Acumen Pharmaceuticals is the larger company by market cap ($151.9 million vs $141.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABOS | ARMP |
|---|---|---|
| Share price | $2.10 | $3.81 |
| Market cap | $151.87M | $141.66M |
| 1-day change | +3.45% | -1.04% |
| YTD return | -0.47% | -39.33% |
| 1-year return | +11.70% | +21.34% |
| 5-year return | -84.50% | +10.43% |
| EPS (TTM) | $-1.64 | $-5.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.60 | $16.34 |
| 52-week low | $1.50 | $3.09 |
| Distance from 52-week high | -41.67% | -76.68% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +359.32% |
| Average volume | 432.46K | 212.63K |
| Shares outstanding | 72.32M | 37.18M |
| Employees | — | 61 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Acumen Pharmaceuticals in Health Care and Armata Pharmaceuticals in Healthcare.
About Armata Pharmaceuticals
ARMP stock →Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.
Healthcare · Biotechnology · 61 employees
ABOS vs ARMP FAQ
Which is bigger, Acumen Pharmaceuticals or Armata Pharmaceuticals?
Acumen Pharmaceuticals (ABOS) is larger, with a market capitalization of $151.87M compared with $141.66M for Armata Pharmaceuticals (ARMP).
Which stock has performed better over the past year, ABOS or ARMP?
ARMP returned +21.34% over the past 12 months, compared with +11.70% for ABOS (price return, excluding dividends). Past performance does not predict future results.
Are Acumen Pharmaceuticals and Armata Pharmaceuticals in the same industry?
No. Acumen Pharmaceuticals is in the Health Care sector, while Armata Pharmaceuticals is in Healthcare.